|
Mycotoxicoses are diseases caused by mycotoxins, i.e.
secondary metabolites of moulds. Although they occur more
frequently in areas with a hot and humid climate, favourable for
the growth of moulds, they can also be found in temperate zones.
Exposure to mycotoxins is mostly by ingestion, but also occurs by
the dermal and inhalation routes.
Mycotoxicoses often remain
unrecognized by medical professionals, except when large numbers
of people are involved. The present article reviews outbreaks of
mycotoxicoses where the mycotoxic etiology of the disease is
supported by mycotoxin analysis or identification of
mycotoxin-producing fungi. Epidemiological, clinical and
histological findings (when available) in outbreaks of
mycotoxicoses resulting from exposure to aflatoxins, ergot,
trichothecenes, ochratoxins, 3-nitropropionic acid, zearalenone
and fumonisins are discussed.
Introduction Mycotoxins are
secondary metabolites of moulds that exert toxic effects on
animals and humans. The toxic effect of mycotoxins on animal and
human health is referred to as mycotoxicosis, the severity of
which depends on the toxicity of the mycotoxin, the extent of
exposure, age and nutritional status of the individual and
possible synergistic effects of other chemicals to which the
individual is exposed. The chemical structures of mycotoxins vary
considerably, but they are all relatively low molecular mass
organic compounds.
The untoward effect of moulds and fungi was
known already in ancient times. In the seventh and eighth
centuries BC the festival "Robigalia" was established to
honour the god Robigus, who had to be propitiated in order to
protect grain and trees. It was celebrated on 25 April because
that was the most likely time for crops to be attacked by rust or
mildew. In the Middle Ages, outbreaks of ergotism caused by ergot
alkaloids from Claviceps purpurea reached epidemic proportions,
mutilating and killing thousands of people in Europe. Ergotism was
also known as ignis sacer (sacred fire) or St Anthony's fire,
because at the time it was thought that a pilgrimage to the shrine
of St Anthony would bring relief from the intense burning
sensation experienced. The victims of ergotism were exposed to
lysergic acid diethylamide (LSD), a hallucinogen, produced during
the baking of bread made with ergot- contaminated wheat, as well
as to other ergot toxins and hallucinogens, as well as belladonna
alkaloids from mandragora apple, which was used to treat ergotism.
While ergotism no longer has such important implications for
public health, recent reports indicate that outbreaks of human
mycotoxicoses are still possible.
Some mycotoxicoses have
disappeared owing to more rigorous hygiene measures. For example,
citreoviridin-related malignant acute cardiac beriberi
("yellow rice disease" or shoshin-kakke disease in
Japanese) has not been reported for several decades, following the
exclusion of mouldy rice from the markets. Citreoviridin is a
metabolic product of Penicillium citreonigrum, which grows readily
on rice during storage after harvest, especially in the colder
regions of Japan.
Another mycotoxicosis not seen for decades is
alimentary toxic aleukia, common in the 1930s and 1940s in the
USSR. This disease was caused by trichothecenes produced by
Fusarium strains on unharvested grain. General interest in
mycotoxins rose in 1960 when a feed-related mycotoxicosis called
turkey X disease, which was later proved to be caused by
aflatoxins, appeared in farm animals in England. Subsequently it
was found that aflatoxins are hepatocarcinogens in animals and
humans, and this stimulated research on mycotoxins.
There is a
long history of the use of certain moulds in the production of
cheese and salami and in the fermentation of beer and wine. Moulds
are also used in the production of drugs (antibiotics). The
classification of mould metabolites as antibiotics or mycotoxins
is based on their toxicity or beneficial effect in treating
diseases. Some mould metabolites that were initially considered to
be antibiotics (e.g. citrinin) were subsequently found to be
highly toxic, and are currently classified as toxins. Ergot
alkaloids are still used, inter alia, in the treatment of
parkinsonism, as prolactin inhibitors, in cerebrovascular
insufficiency, migraine treatment, venous insufficiency,
thrombosis and embolisms, for the stimulation of cerebral and
peripheral metabolism, in uterine stimulation, as a dopaminergic
agonist. The toxic effects of mycotoxins (e.g. ochratoxins,
fumonisins, zearalenone, etc.) are mostly known from veterinary
practice.
Mycotoxicoses, which can occur in both industrialized
and developing countries, arise when environmental, social and
economic conditions combine with meteorological conditions
(humidity., temperature) which favour the growth of moulds.
Involvement of mycotoxins in disease causation should be
considered in instances when a disease appears in several persons,
with no obvious connection to a known etiological agent, such as
microorganisms. Given current trade patterns, mycotoxicoses
resulting from contaminated food, locally grown or imported, could
occur in developing and developed countries alike. Strict control
of food and feed and appropriate public health measures are
therefore of considerable importance in reducing the risks to
human and animal health. This review covers only the human aspects
of the untoward effects of mycotoxins.
However, owing to the
frequent nonspecific effects of mycotoxin involvement, the results
of animal experiments are useful for understanding possible
effects on humans. Since review articles and books are available
dealing with specific topics such as the chemistry, analytical
procedures, metabolism, and economic aspects of mycotoxins (9-18),
these aspects of mycotoxin toxicology are not presented here.
Mycotoxicoses are usually insufficiently treated in medical
textbooks and are not covered in curricula of many medical
schools. The aim of this article is to summarize current
understanding of the clinical aspects mainly of mycotoxicoses in
humans, and to stress the importance of this class of naturally
occurring toxins. Ergot Ergot is the common name of the sclerotia
of fungal species within the genus Claviceps, which produce ergot
alkaloids. The sclerotium is the dark-coloured, hard fungal mass
that replaces the seed or kernel of a plant following infestation.
Ergot alkaloids are also secondary metabolites of some strains of
Penicillium, Aspergillus and Rhizopus spp. The ca. 40 ergot
alkaloids isolated from Claviceps sclerotia can be divided into
three groups: derivatives of lysergic acid (e.g. ergotamine and
ergocristine); derivatives of isolysergic acid (e.g.
ergotaminine); derivatives of dimethylergoline (clavines, e.g.
agroclavine). The source of the ergot strongly influences the type
of alkaloids present, as well as the clinical picture of ergotism.
Claviceps purpurea produces ergotamine-ergocristine alkaloids,
which cause the gangrenous form of ergotism because of their
vasoconstrictive activity. The initial symptoms are oedema of the
legs, with severe pains. Paraesthesias are followed by gangrene at
the tendons, with painless demarcation. The last-recorded outbreak
of gangrenous ergotism occurred in Ethiopia in 1977-78; 140
persons were affected and the mortality was high (34%). The other
type of ergotism, a convulsive form related to intoxication with
clavine alkaloids from Claviceps fusiformis was last seen during
1975 in India when 78 persons were affected. It was characterized
by gastrointestinal symptoms (nausea, vomiting and giddiness)
followed by effects on the central nervous system (drowsiness,
prolonged sleepiness, twitching, convulsions, blindness and
paralysis). The onset of symptoms occurred 1-48 hours following
exposure; there were no fatalities. Ergotism is extremely rare
today, primarily because the normal grain cleaning and milling
processes remove most of the ergot so that only very low levels of
alkaloids remain in the resultant flours. In addition, the
alkaloids that are the causative agents of ergotism are relatively
labile and are usually destroyed during baking and cooking.
Aflatoxins Aflatoxins occur in nuts, cereals and rice under
conditions of high humidity and temperature and present a risk to
human health that is insufficiently recognized. The two major
Aspergillus species that produce aflatoxins are A. flavus, which
produces only B aflatoxins, and A. parasiticus, which produces
both B and G aflatoxins. Aflatoxins [M.sub.1] and [M.sub.2] are
oxidative metabolic products of aflatoxins [B.sub.1] and [B.sub.2]
produced by animals following ingestion, and so appear in milk
(both animal and human), urine and faeces. Aflatoxicol is a
reductive metabolite of aflatoxin [B.sub.1]. Aflatoxins are
acutely toxic, immunosuppressive, mutagenic, teratogenic and
carcinogenic compounds. The main target organ for toxicity and
carcinogenicity is the liver. The evaluation of epidemiological
and laboratory results carried out in 1987 by the International
Agency for Research on Cancer (IARC) found that there is
sufficient evidence in humans for the carcinogenicity of naturally
occurring mixtures of aflatoxins, which are therefore classified
as Group 1 carcinogens, except for aflatoxin [M.sub.1], which is
possibly carcinogenic to humans (Group 2B). Several outbreaks of
aflatoxicosis have occurred in tropical countries, mostly among
adults in rural populations with a poor level of nutrition for
whom maize is the staple food. The clinical picture presented by
cases indicated acute toxic liver injury, which was confirmed by
morphological changes in liver autopsy specimens that were
indicative of toxic hepatitis. Mortality rates in the acute phase
were 10-60 %. At the end of one year, surviving patients had no
jaundice, and most of them had recovered clinically.
A case of
attempted suicide with purified aflatoxin [B.sub.1] is reported to
have occurred in 1966 in the USA. A young woman ingested a total
of 5.5 mg of aflatoxin [B.sub.1] over 2 days and, 6 months later,
a total of 35 mg over 2 weeks. Following the first exposure, she
was admitted to hospital with a transient, nonpruritic, macular
rash, nausea and headache; the second time she reported nausea
only. On both occasions, physical, radiological and laboratory
examinations were normal and liver biopsies appeared normal by
light microscopy. A follow-up examination 14 years later did not
reveal any signs or symptoms of disease or lesions. These findings
suggest that the hepatotoxicity of aflatoxin [B.sub.1] may be
lower in well nourished persons than in experimental animals or
that the latent period for turnout formation may exceed 14 years.
Aflatoxins have been detected in the blood of pregnant women, in
neonatal umbilical cord blood, and in breast milk in African
countries, with significant seasonal variations. Levels of
aflatoxins detected in some umbilical cord bloods at birth are
among the highest levels ever recorded in human tissue and fluids.
Aflatoxins have been suggested as an etiological factor in
encephalopathy and fatty degeneration of viscera, similar to Reye
syndrome, which is common in countries with a hot and humid
climate. The clinical picture includes enlarged, pale, fatty liver
and kidneys and severe cerebral oedema.
Aflatoxins have been found
in blood during the acute phase of the disease, and in the liver
of affected children. However, use of aspirin or phenothiazines is
also suspected to be involved in the etiology. In tropical
countries, clinically recognizable jaundice is frequent during the
neonatal period. In a large investigation undertaken on 327 Babies
with jaundice and 80 matching controls in Nigeria, it was found
that the occurrence of glucose-6-phosphate dehydrogenase (G6PD)
deficiency together with the presence of aflatoxins in the serum
are significant risk factors for the development of neonatal
jaundice. The geographical and seasonal prevalences of aflatoxins
in food and of kwashiorkor show a remarkable similarity. In
several tropical countries, aflatoxins have been found more
frequently and in higher concentration in liver specimens from
children with kwashiorkor than in controls. Clinical investigation
of aflatoxin elimination in children with kwashiorkor and marasmic
kwashiorkor, who were fed an aflatoxin-free diet, proved that
aflatoxins in these children are slowly eliminated. In several
studies, aflatoxicol was found in the serum, liver, urine and
stools of children with kwashiorkor and marasmic kwashiorkor, in
contrast to marasmic and control children where this metabolite
was not found. It is not clear whether this difference is causally
related to kwashiorkor or is a consequence of the disease. In
recent studies, aflatoxins were found in the brain and lungs of
children who had died from kwashiorkor and in control children who
had died from various other diseases.
It was suggested that the
presence of aflatoxins in the brains of control children might be
due to metabolic imbalance or to a failure in the excretory
mechanisms of children with conditions such as measles (which in
25% of cases precedes kwashiorkor), renal failure, pyloric
stenosis, gastroenteritis. Aflatoxins in the lungs were found in
all children diagnosed to have pneumonia, irrespective of the
presence of kwashiorkor. This could be due to a reduced clearing
ability of the lungs in pulmonary diseases or to exposure via the
respiratory route. In the Philippines, a study of the relationship
between the presence of aflatoxin in the serum and urine of
children and the outcome of acute lower respiratory infection
failed to prove a correlation. However, aflatoxin [B.sub.1] was
found in the lungs of one textile and two agricultural workers who
died from pulmonary interstitial fibrosis. These individuals were
probably occupationally exposed to aflatoxin [B.sub.1] via the
respiratory route. Aflatoxin [B.sub.1] was also detected in the
lung tissue of a chemical engineer who had worked for 3 months on
a method for sterilizing Brazilian peanut meal contaminated with
Aspergillus flavus, and who died of alveolar cell carcinoma. In
the United Kingdom, it was found that intravenous heroin users can
be exposed to aflatoxin [B.sub.1] from samples of heroin on sale.
Through intravenous administration, aflatoxin [B.sub.1] bypasses
the detoxifying mechanisms of the liver, which results in direct
systemic exposure. In the United Kingdom and the Netherlands,
analysis of 121 urine samples obtained from heroin addicts
revealed a higher proportion of samples contaminated with
aflatoxins [B.sub.1], [B.sub.2], [M.sub.1] and [M.sub.2] and
aflatoxicol (20%) than those from normal adult volunteers (2%). In
addition, aflatoxin [B.sub.1] was found at much lower
concentrations in the latter group. 3-Nitropropionic acid
3-Nitropropionic acid (3-NPA) is a secondary metabolite of
Arthrinium sp., considered to cause a form of acute food-poisoning
called "mouldy sugarcane poisoning". The problem
occurred during winter (February and March) in 13 provinces of
northern China as a consequence of ingesting sugarcane that had
been stored for at least two months and which was infested with
Arthrinium sp. In the period 1972-88, a total of 884 persons were
involved in outbreaks, with 88 (10%) fatalities. The main
epidemiological feature is the small number of persons in one
outbreak (one to five persons), with the victims being mostly
children and young people. The incubation period is generally 2-3
hours following the ingestion of mouldy sugar-cane, and the main
clinical symptoms are vomiting, dystonia, staring to one side,
convulsions, carpopedal spasm and coma. Delayed dystonia develops
in 10-50 % of patients as a consequence of bilateral symmetric
necrosis of the basal ganglia. The development of delayed symptoms
can be predicted by abnormality in the basal ganglia on cranial
computed tomography (CT) scans. In adults, 3-NPA causes
gastrointestinal symptoms; signs of severe encephalopathy are not
common. Ochratoxins Ochratoxins are secondary metabolites of
Aspergillus and Penicillium strains, found on cereals, coffee and
bread, as well as on all kinds of food commodities of animal
origin in many countries. The most frequent is ochratoxin A, which
is also the most toxic. It has been shownn to be nephrotoxic,
immunosuppressive, carcinogenic and teratogenic in all
experimental animals tested so far. Acute renal failure in one
person, possibly caused by inhalation of ochratoxin A in a granary
which had been closed for 2 years, was reported in Italy. The
symptoms developed after 24 hours of transitory epigastric
tension, respiratory distress, and retrosternal burning. Acute
tubular necrosis was found on biopsy, but the blood was not
analysed for ochratoxin A.
The presence of the mycotoxin in wheat
from the granary was proved qualitatively by thin-layer
chromatography. Owing to the similarity of morphological and
functional kidney lesions in ochratoxin A-induced porcine
nephropathy and endemic nephropathy, this mycotoxin has been
proposed as the causative agent of endemic nephropathy, although
the evidence for this is not substantial. This fatal renal disease
occurs among rural populations in Croatia, Bosnia and Herzegovina,
Yugoslavia, Bulgaria, and Romania, where it has been estimated
that about 20,000 people are either suffering from or are
suspected to have the disease. There is no acute phase of the
illness; the first signs and symptoms of the disease are not
specific and include fatigue, headache, loss of body weight and
pale skin. A mild low-molecular-mass proteinuria without
hypertension but with either aplastic or normochromic anaemia
gradually develops over several years. The main features of
endemic nephropathy are bilateral, primarily chronic lesions of
the renal cortex (tubular degeneration, interstitial fibrosis and
hyalinization of the glomeruli). In the advanced stage of the
disease, the size and weight of kidneys are remarkably reduced,
with diffuse cortical fibrosis, usually without signs of
inflammation. Ochratoxin A is found more frequently and in higher
concentrations in the blood of inhabitants from endemic regions
than control regions. Many samples of locally produced food and
feed collected in the endemic area contained ochratoxin A. It
should be emphasized that the grain analysed had been kept for
many months in the inadequate food stores of individual families.
In Tunisia, ochratoxin A has been detected in high concentrations
in the blood and food of patients with kidney impairment of
unknown etiology. It has also been found in several countries,
both in food and feed and in humans. In endemic regions of
Croatia, Bulgaria and Yugoslavia, the incidence of otherwise rare
urothelial tumours of the pelvis and ureter is 50, 90 and 100
times greater, respectively, than in nonendemic regions. It has
been suggested that ochratoxin A may be the causal agent for both
endemic nephropathy and urothelial tumours. IARC classified
ochratoxin A as a compound possibly carcinogenic to humans (Group
2B). Trichothecenes Trichothecenes are mycotoxins produced mostly
by members of the Fusarium genus, although other genera (e.g.
Trichoderma, Trichothecium, Myrothecium and Stachybotrys) are also
known to produce these compounds. To date, 148 trichothecenes have
been isolated, but only a few have been found to contaminate food
and feed. The most frequent contaminants are deoxynivalenol (DON),
also known as vomitoxin, nivalenol (NIV), diacetoxyscirpenol
(DAS), while T-2 toxin is rarer. Common manifestations of
trichothecene toxicity are depression of immune responses and
nausea, sometimes vomiting. The first recognized trichothecene
mycotoxicosis was alimentary toxic aleukia in the USSR in 1932;
the mortality rate was 60%. In regions where the disease occurred,
540% of grain samples cultured showed the presence of Fusarium
sporotrichoides, while in those regions where the disease was
absent this fungus was found in only 2-8% of samples.
The severity
of mycotoxicosis was related to the duration of consumption of
toxic grain. Such severe trichothecene mycotoxicoses, the
consequence of continuous ingestion of toxins, have not been
recorded since this outbreak. In several cases, trichothecene
mycotoxicosis was caused by a single ingestion of bread containing
toxic flour or rice. In experimental animals, trichothecenes are
40 times more toxic when inhaled than when given orally.
Trichothecenes were found in air samples collected during the
drying and milling process on farms, in the ventilation systems of
private houses and office buildings, and on the walls of houses
with high humidity. There are some reports showing trichothecene
involvement in the development of "sick building
syndrome". The symptoms of airborne toxicosis disappeared
when the buildings and ventilation systems were thoroughly
cleaned. Zearalenone Zearalenone (previously known as F-2) is
produced mainly by Fusarium graminearum and related species,
principally in wheat and maize but also in sorghum, barley and
compounded feeds. Zearalenone and its derivatives produce
estrogenic effects in various animal species (infertility, vulval
oedema, vaginal prolapse and mammary hypertrophy in females and
feminization of males -- atrophy of testes and enlargement of
mammary glands). In Puerto Rico, zearalenone was found in the
blood of children with precocious sexual development exposed to
contaminated food. Zearalenone was also found together with other
Fusarium mycotoxins in "scabby grain toxicosis" in
China, but the significance of this finding is not clear.
Fumonisins Fumonisins are mycotoxins produced throughout the world
by Fusarium moniliforme and related species when they grow in
maize. Fumonisins [B.sub.1] and [B.sub.2] are of toxicological
significance, while the others (B.sub.3], [B.sub.4], [A.sub.1] and
[A.sub.2]) occur in very low concentrations and are less toxic. In
India a single outbreak of acute foodborne disease possibly caused
by fumonisin [B.sub.1] has been reported. In the 27 villages
involved, the individuals affected were from the poorest social
strata, who had consumed maize and sorghum harvested and left in
the fields during unseasonable rains. The main features of the
disease were transient abdominal pain, borborygmus and diarrhoea,
which began half an hour to one hour following consumption of
unleavened bread prepared from mouldy sorghum or mouldy maize.
Patients recovered fully when the exposure ceased and there were
no fatalities.
Fumonisin [B.sub.1] was found in much higher
concentrations in the maize and sorghum from the affected
households than from controls. Fumonisin [B.sub.1] was found more
frequently and in much higher concentrations in maize in regions
of Transkei, China and north-east Italy with a higher incidence of
oesophageal cancer than other regions. It was postulated that the
high incidence of oesophageal cancer was related to the presence
of this mycotoxin in maize, which is a staple food in these
regions. The incidence and concentration of aflatoxin [B.sub.1],
deoxynivalenol and fumonisins [B.sub.1], [B.sub.2] and [B.sub.3]
were recently determined in maize samples from an area of China
(Haimen) with a high incidence of primary liver cancer and from an
area with a low incidence (Penlai). Aflatoxin [B.sub.1] was found
in low concentrations in almost all maize samples from both these
areas, but the incidence and concentration of deoxynivalenol and
fumonisins were much higher in the samples from the area where the
incidence of primary liver cancer was high. The authors put
forward the hypothesis that fumonisins, which have known
cancer-promoting activity in rat liver, and deoxynivalenol promote
the initial lesion caused by aflatoxin [B.sub.1]. An IARC working
group classified the toxins from F. moniliforme as possibly
carcinogenic to humans (Group 2B). Other unidentified mycotoxins
The impact of other mycotoxins on human health was reported in
persons occupationally exposed to large amounts of different
mycotoxin-producing fungi (farmers, workers in silos, etc.). In
such cases, exposure to spores via the respirator), tract seems to
be of considerable importance. In Norway an extensive
epidemiological study was undertaken between 1967 and 1991 on 192
417 births to test the hypotheses that perinatal death was
associated with parental exposure to pesticides, Toxoplasma gondii
infection from sheep or pigs, or mycotoxins found in grain. The
proportion of late-term abortions (gestational age 16-27 weeks)
was higher among farmers. The risk associated with grain farming
was higher after the harvest, in seasons with a poor quality
harvest and in pregnancies with multiple fetuses, which suggests
that mycotoxins in grain induce labour at an early stage of
pregnancy. Pulmonary mycotoxicosis has been reported in ten
persons exposed to large quantities of fungal hyphae and spores
during the cleaning of silos. The clinical picture developed
several hours afterwards, with burning eyes, throat and chest,
irritating cough and fever. There was no wheezing, cyanosis or
other sign of bronchospasm. In five patients, chest X-rays
revealed reticular and fine nodular features compatible with
interstitial pneumonitis.
Histological study of a lung biopsy from
one patient showed a multifocal acute process, with primary
involvement of terminal bronchioles containing numbers of various
spores. Cultures from lung biopsy material revealed at least five
fungal species, including one Fusarium and one Penicillium.
However, blood samples were not checked for the presence of
mycotoxins. In contrast with the findings in patients with
farmer's lung disease, these patients did not develop positive
serological reactions to thermophilic actinomycetes or to extracts
of fungi obtained from hay or silage. The patients were followed
for periods of 1-10 years; they continued their work, avoiding
massive re- exposure to fungal dust, and during the observation
period there were no further incidents. Conclusion Acute
mycotoxicoses can cause serious and sometimes fatal diseases. The
possibility of mycotoxin intoxication should be considered when an
acute disease occurs in several persons when there is no evidence
of infection with a known etiological agent, and no improvement in
the clinical picture following treatment. Most of the outbreaks of
mycotoxicoses described are a consequence of the ingestion of food
that is contaminated with mycotoxins. The strict control of food
quality, in both industrialized and developing countries, is
therefore necessary to avoid such outbreaks.
Acknowledgements We
thank Dr R. Plestina for supervision and advice in all phases of
the preparation of this paper. Toxic
Effects of Mycotoxins in Humans September 1, 1999 Bulletin of the
World Health Organization By Peraica, M.; Radic, B.; Lucic, A.;
Pavlovic, M.
- |